Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

desloratadine-pseudoephedrine

desloratadine-pseudoephedrine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Clarinex-D 12 Hour TABLET, EXTENDED RELEASE, ORAL 2.5 mg-120 mg    
Clarinex-D 24 Hour TABLET, EXTENDED RELEASE, ORAL 5 mg-240 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

desloratadine-pseudoephedrine (Clarinex-D 12 Hour)

  • 2.5 mg-120 mg extended release tablet oral BID

loratadine-pseudoephedrine (Claritin-D 24 Hour)

  • 10 mg-240 mg extended release tablet oral Daily

desloratadine-pseudoephedrine (Clarinex-D 24 Hour)

  • 5 mg-240 mg extended release tablet oral

loratadine-pseudoephedrine (Claritin-D 24 Hour)

  • 10 mg-240 mg extended release tablet oral Daily

Reviewed: March 28, 2006 (Clarinex D-12 hour)

Last updated: Dec. 15, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved